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Patient and Provider Views on Informed Consent for Cardiac Catheterization:
A Pilot Study
Jarrod D. Frizzell, BS, MD, MS
ABSTRACT
Background: Patient provision of informed consent is foundational to medical decisionmaking. However, clinical informed consent is not as well studied as consent for
research. Cardiac catheterization (CC) is a complex medical procedure with many
potential variations, making informed consent challenging.
Objective: To determine patient and provider attitudes toward the informed consent
process for CC and to test a new measure for measuring patient capacity to consent for
CC.
Design: A mixed methods pilot study.
Setting: Academic medical center.
Participants: 8 patients who consented for non-emergent CC, cardiology fellows and
faculty (21 surveyed, 7 interviewed).
Measurements: Patients and providers underwent semi-structured interviews, which
were qualitatively coded for themes. Patients completed an instrument designed to
measure capacity to consent for CC. Providers completed a survey to gauge attitudes
about the consent process for CC.
Results: Most patients (75%) did not meet the 70% performance testing for capacity
derived from a provider survey as a minimum for providing consent. Patients did not
view the consent discussion as part of medical decision-making. In emergent situations,
patients requested that providers apply pressure to convince patients to undergo
necessary procedures. Providers believed proper informed consent was important, but
admitted to less emphasis in emergencies, and they often used family to help patient
consent in such situations. Patient and providers described common themes in informed
consent.
Conclusions: The instrument developed herein for measuring capacity to consent for
CC has promise for providing valid and reliable data. Most patients tested did not have
capacity by criteria set by providers, suggesting that the informed consent process was
inadequate. Patients and providers expressed a role for applying pressure to convince
patients to consent to emergent procedures.
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Introduction
Acquiring informed consent prior to conducting medical procedures is an ethical
and legal requirement of healthcare providers. Over the latter half-century, physicians
have steadily supplanted the paternalistic model of physician-patient interaction with
other models that emphasize patient autonomy, including active patient participation and
shared decision-making (1, 2). Adequate informed consent for clinical procedures is a
cornerstone of these other models, but it is a continual struggle to provide the
appropriate amount of information at the appropriate level (3) and to ensure that patients
appreciate complex medical information. However, the primary driving force behind
much of the literature on informed consent concerns research trials, rather than clinical
practice. This is likely a reflection of the impact of the Nuremburg Code, Declaration of
Helsinki, and the Belmont Report, among others, on the growth of the field of biomedical
ethics from human subjects research (4). Informed consent for medical treatments, on
the other hand, originated more from case law with a focus on explication of risks (5). As
such, the gathering of informed consent in practice for clinical procedures may have
quite different requirements and implications (6). For instance, the threshold of capacity
for informed consent for research may be higher, owing to the nature of experimentation
and delineating as yet unknown risks in the context of little to no potential benefit to the
individual subject (5). Further, as medical treatments by definition are designed to act to
improve the condition of the patient, informed consent for clinical practice does not face
the significant obstacle of therapeutic misconception (7).
A core precondition for informed consent is providing situation-specific
information to the patient. Several methods with varying successes have attempted to
bridge the information divide between patient and provider, owing to the difference
between provider expertise and knowledge, and the patient’s lack thereof. These
methods include improved readability of forms, having extensive discussions, and using
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multimedia programs (8-11). The visual communication of risk levels using images has
also been shown to increase effectiveness of informed consent procedures (12).
Attractive as advanced audiovisual multimedia may be, simpler aids were often found to
be more effective than complex aids to decision-making (9). However, studies on
improving the process informed consent, or improving patient understanding and
appreciation of invasive medical procedures, have a high degree of methodological
heterogeneity, making conclusions as to the most effective methods difficult (10, 11).
That is, the studies differ by more than simply the method used, thus confounding the
meaning of outcomes across studies.
Aside from the information proper, such as understanding the “facts” of what the
procedure involves, achieving informed consent also means that patients must have the
capacity to make an informed decision. Although differing legal nuances of capacity
have been delineated, a consistent thread involves four domains: understanding,
appreciation, reasoning, and expression of choice (13, 14). Gurrera et al. perhaps best
distinguish these facets as (13):
1. Understanding—comprehension of diagnostic and treatment
information.
2. Appreciation—personalization of information through integration
with one’s values, beliefs, and expectations.
3. Reasoning—evaluation of treatment alternatives in light of
potential consequences for everyday life.
4. Expression of choice—communication of a treatment decision.
Assessment of these 4 domains can prove challenging. For instance,
appreciation is harder to measure than is comprehension (15), and physicians often
have difficulty assessing appreciation (16). Several instruments have attempted to
measure patient capacity to consent (17) although practical application of these
instruments has been limited. Shortcomings include: inadequate evaluation of validity
and reliability of data from differing (nonspecialized) patient populations, time involved,
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possible need for training (nonclinician) assessors, and relevance to clinical practice,
among others (17).
Cardiac catheterization (CC) presents an excellent opportunity for evaluating the
process of informed consent in the clinical setting. CC is a complex procedure with many
possible variations, depending on the needs of the patient and what is found during the
procedure. Although the primary indication is for diagnostic purposes, often patients are
asked in advance to consent for additional (therapeutic) procedures to be done in media
res depending on findings during the procedure. Generally, providers feel it more
prudent to obtain consent for these possible secondary procedures up front (18).
Moreover, many CCs are performed on an urgent or emergent basis, when informed
consent is very difficult or impossible (19). Because of these issues, finding a simple
method to improve patient understanding and appreciation for CC is important (20).
Few studies have examined informed consent in CC. Two were observational
and showed patients grossly underestimated risks and overestimated benefits for
coronary angioplasty (21), particularly when compared to cardiologists’ judgments (22).
One study found no difference in patient recall, satisfaction or anxiety comparing written,
verbal or animated methods (23). Another study found that an interactive computerbased consent process for CC mildly increased patient understanding and appreciation
compared to the standard consent process (24).
Finally, there is a paucity of studies that examine the provision of informed
consent from the perspective of providers, especially in comparison to patient
understanding and appreciation for the procedure. One study showed that patient beliefs
regarding the benefits of percutaneous coronary intervention differed significantly from
that of cardiologists (22). However, the authors did not measure cardiologist
expectations of patient understanding, appreciation, or compare attitudes about the
consent between the two groups. A disconnect between patient and provider
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perspectives may have a great impact on the acquisition of legitimate informed consent
itself, and presents ample opportunities for improvement of informed consent
procedures. A comprehensive review of the literature found only one study directly
comparing physician and patient attitudes toward informed consent, and it involved
consent for blood transfusions. In this study, a majority of physicians and patients
thought that the informed consent procedure was inadequate (25).
The purpose of the present study is to examine the process of informed consent
for CC from the perspectives of both patient and provider. The specific aims of this study
are as follows:
1. Identify current baseline for patient understanding and appreciation for CC at
UNMH.
a. Develop and test a new instrument for measuring patient capacity to
consent for CC.
b. Compare patient self-rating of understanding with objective measures on
the instrument.
2. Identify current provider attitudes and expectations regarding informed
consent for CC at UNMH.
a. Derive a patient threshold for capacity to consent from provider views.
3. Compare UNM provider and patient attitudes toward the informed consent
process for CC.
This study directly measures patient understanding and appreciation of the
procedure, risks, benefits, and alternatives for diagnostic CC with the current informed
consent process at the University of New Mexico Hospital (UNMH). Patient
understanding and appreciation of the risks, benefits, and alternatives of cardiac
catheterization is not well described for UNMH’s unique population mix. UNMH serves a
population similar to the state of New Mexico, dominated by about 47% Hispanics and
40% non-Hispanic whites (26). Nearly 20% of the population lives below the federal
poverty level (26). Educational attainment in New Mexico is less than the United States
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average, with approximately 83% of adults being high school graduates or having higher
education, and nearly 26% obtaining a college bachelor’s degree or higher (26). As
such, UNMH’s patient population largely fits the description of “vulnerable patients” who
are at higher risk of providing inadequately informed consent (27). This study also will
examine the relationship between patients’ subjective views of their own understanding
and their objectively measured understanding and appreciation. In addition, patients also
describe their thoughts on the informed consent discussion during emergent situations.
Further, although there are several instruments in the literature to assess patient
capacity to consent to treatment (17), none are specific for CC. To help address this gap
in the literature, this study provides objective measurements of patient understanding
and appreciation and develop an instrument specifically designed for CC. In a study of
informed consent such as the present study, it is possible that a researcher might
identify a patient with low level of understanding and appreciation of the risks, benefits,
and alternatives of the clinical procedure of cardiac catheterization, as measured on the
present study’s instrument. This presents an ethical dilemma to the researcher: Should
the researcher inform the provider who had just gained informed consent from the
patient for CC, thus suggesting that the patient’s previous given informed consent for CC
be invalidated, or should the researcher not interfere with the clinical informed consent
procedure that has already been completed? If the researcher informs the provider of
the apparent lack of capacity to consent for the clinical procedure, the provider could
then seek a legally authorized representative, such as a next-of-kin of the patient, to
provide informed consent for CC. However, the provider is already assuming the patient
has provided his/her informed consent for CC, and if the research on informed consent
for CC had not been done in parallel to the clinical procedure of CC, then there would
have been no indication to the provider of lack of capacity for informed consent for CC.
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The latter is the case, presumably, in many clinical procedures in which formal
assessments of capacity for informed consent are rarely conducted.
Although a known issue in research on informed consent (28), this situation is
particularly challenging. Based on a review of the literature, one way to deal with this is
to incorporate awareness of patient self-efficacy and empowerment, particularly in
patients with low health literacy (29). Utilizing a prompt encouraging patients to contact
their provider with additional questions may increase patient willingness to discuss
confusing issues further and gain more information (29).
Last, this study examines the views of providers on the informed consent process
for CC. This includes not only the minimal requirements providers believe are necessary
to provide informed consent, but also gauges provider attitudes about what they see as
challenging aspects of the informed consent process. Providers also explore their
formative experiences for the process of informed consent, what expectations they have
of patients during the process, and attempt to describe the process from the patients’
perspectives. In addition, providers describe their thoughts on obtaining informed
consent during emergent situations, and whether and how their expectations change
compared to an elective procedure.
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Methods
This is a mixed-methods preliminary study using both qualitative and quantitative
data gathered from patients and providers regarding attitudes toward the informed
consent process for cardiac catheterization (CC). Results from this study will be used to
support future studies, including the seeking of external grant funding to further study
informed consent for cardiac procedures in clinical practice. The Human Research
Review Committee (HRRC, i.e., Institutional Review Board) at the University of New
Mexico Health Sciences Center approved this study.
Participants
A convenience sample of patients was recruited from the UNMH cardiac
catheterization laboratory. Inclusion criteria for patients in this study are as follows: ≥18
years old, have an indication for non-emergent cardiac catheterization, and have the
capacity to provide informed consent according to the treating provider. Exclusion
criteria included an indication for emergent cardiac catheterization (e.g., ST-elevation
myocardial infarction, cardiogenic shock), or judged by treating providers to lack capacity
for consent. Up to 12 patients were planned to be recruited, with an even mix among
Hispanic, non-Hispanic white, men, and women.
All cardiology fellows (n = 12) and faculty (n = 19) at the University of New
Mexico were eligible for inclusion in this study. All providers were eligible for completion
of the survey. All fellows were eligible for participation in semi-structured interviews.
Attendings that performed CC were specifically targeted for interviews.
Capacity to Consent Instrument
In the course of completing the semi-structured interviews, patients also
completed a series of 11 questions to assess their capacity to provide informed consent
for CC. This informed consent capacity instrument for the present study is based on
assessment methods for capacity to consent recommended by our institution’s Human
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Research Protection Office (30), which in turn was influenced by the Human Research
Protection Program at the University of California, San Diego (31). The original
instrument, the University of California, San Diego Brief Assessment of Capacity to
Consent (UBACC) (32) was modified to make it specific to CC procedures used at the
University of New Mexico Hospital (the Capacity to Consent for Cardiac Catheterization
instrument, or C4 for short) (Figure 1). This new instrument has the advantage of
addressing three of the domains of informed consent: understanding (items 1, 3, 7, 8,
11), appreciation (items 4, 5, 6, 9, 10), and reasoning (item 2). Patients demonstrated
expression of choice by being willing to undergo CC and subsequently signing the
consent form after discussion with their provider. Also as part of the completing the
interviews, patients described their highest level of educational attainment. Education
level was used as a proxy variable for health literacy in this preliminary study because
other studies have suggested a strong predictive value of education for health literacy
(33).
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Figure 1. Capacity to Consent for Cardiac Catheterization Instrument Questions with
Fully Correct Answers Shown.*
1.

What are the symptoms you have that made your doctor recommend this procedure just described
to you?
2 = symptoms consistent with obstructive coronary artery disease (CAD) and/or valve disorder

2.

What is your doctor trying to get done when he or she performs the catheterization just described to
you?
(Overall purpose of the procedure—general descriptors, more open-ended)
2 = trying to figure out the cause of symptoms and/or need for coronary artery bypass surgery
(CABG) concomitant with valve surgery

3.

What is the main reason for your doctor to perform the catheterization?
Main reason for these non-emergent cases
2 = diagnose the presence of obstructive CAD

4.

Do you have to have this procedure if you do not want to have it?
2 = no

5.

If you decide not to have this procedure, what are the other things you can choose to do to get
diagnosed or treated?
Alternatives
2 = list one or more alternatives for either diagnosing or treating

6.

Please describe what your doctor will actually do when he or she performs the catheterization.
2 = involves tube going to heart from groin or wrist, use of dye to look for blockages in heart
arteries

7.

Please describe some serious harmful things that could happen to you if you have this procedure.
2 = describes at least three complications/risks, including at least two of the following: death,
stroke, heart attack

8.

Please describe some ways that you might be helped if you have this procedure.
2 = describes at least one appropriate benefit of the procedure (e.g., symptom relief, information
regarding presence of blockages prior to valve replacement, etc.)
Note: As all cases are non-emergent (not ST-elevation myocardial infarction or cardiogenic shock),
life-saving would not be a correct answer.

9.

If you have this procedure, is it possible that you will not be helped at all?
2 = yes, it is possible that won’t be “helped” as far as symptoms; would also accept gaining
information as to presence/absence of obstructive CAD as part of diagnostic workup (explanation
of symptoms, pre-operative evaluation for valve replacement, etc., if adequately reasoned)

10. If the results show you have blockage in an artery, what might be the next steps in your treatment?
2 = stent placed if appropriate based on symptoms, CABG if valve replacement, possibly CABG if
not valve replacement
11. After the procedure is over, what are some symptoms that you might have that you should call and
tell your doctor about?
2 = able to list at least three signs/symptoms concerning for a complication

* Fully complete answers from patient participants that convey the essential meaning of the
response shown in the table are scored 2 points; partially correct answers scored are scored 1
point. A total score summing the points earned for all 11 items produce an overall score of 0 to
22.
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At the end of the interview, the interviewer explicitly encouraged patients using
language such as “Now that you have discussed this procedure and the process of
learning about it in depth with me, think about whether you can state how serious the
potential drawbacks and benefits of the procedure are, and consider whether you would
like to know more about the risks and benefits. Please contact your nurse or provider if
you have additional concerns.” As compensation for their time and effort, the investigator
gave patients $20 in the form of an unrestricted Visa gift card.
Procedures
Recruitment of all patients occurred within 20 minutes of the CC consent
discussion and the patient’s signing of the consent form. A diverse group of providers
were involved in the consent discussions with patient participants in the present study
(including at least one attending, fellow, and mid-level provider involved among the
patient discussions). Due to the nature of the study in examining the role of informed
consent per se, and that no changes in clinical treatment would be made, the present
study’s informed consent was an abbreviated oral consent, as approved by the HRRC. A
clear distinction was made to patients between consent for this study and informed
consent for the clinical procedure of CC. The interaction with patients made it clear to
them that their participation in this informed consent study would make no difference in
their treatment for cardiac problems as previously determined by the patient and his or
her provider.
An announcement at a fellows’ meeting served for recruitment of cardiology
fellows for completion of the semi-structured interviews, and 4 fellows were interviewed
on a first-come, first-serve basis, as well as 3 faculty cardiologists who perform cardiac
catheterizations (2 interventional cardiologists, 1 invasive cardiologist). The survey (see
Appendix 1) was distributed by email, directly at fellows’ conference, and by placing
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physical copies in the mailboxes of fellows and attendings. Instructions for returning the
survey anonymously were also provided.
Analysis
Patient and providers independently underwent semi-structured interviews.
Interviews were transcribed for qualitative analysis using code structures that emerged
from each set of interviews. After the completion of 8 patient interviews, a pre-specified
interim analysis of codes was performed to assess for thematic saturation. If the analysis
showed that thematic saturation had been reached, no further patient interviews would
be performed. All target provider interviews were completed prior to analysis for coding
(3 attending cardiologists, 4 fellows). The qualitative data software Dedoose (Dedoose
version 4.5, Los Angeles, CA) was used to facilitate coding. For analysis, codes that
emerged from a minimum of 2 participants in each group were considered to qualify for
integration into a theme for further analysis. When appropriate, patient and provider
themes were directly compared.
Two cardiologists independently scored completed the C4 instrument according
to the 0-2 scoring system as described in Figure 1, a scale recommended in the original
instrument (32) and in other instruments measuring patient comprehension (34). A
weighted κ was used to assess for inter-rater variability as well as calculation of
Spearman’s rank correlation coefficient. The raters settled disagreements in codes by
discussion to determine the final scores for each item. Descriptive statistics for final
patient scores, including mean and standard deviations, were calculated. To evaluate
validity of the data, bivariate correlations among the C4 items using Spearman’s r were
calculated. Final scores and subtotals for each consent domain (understanding,
appreciation, and reasoning) were used to calculate Cronbach’s α to measure internal
consistency of the instrument. Patients rated their own level of understanding of the
informed consent information for CC on a scale from 0 = not understand at all to 10 =
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understand completely. Patient self-ratings were correlated with actual scores on the C4
informed consent assessment instrument using pairwise correlation. I also conducted a
two-tailed paired t-test (α=0.05) to evaluate mean scores between patient self-ratings
(transformed to a 0-100 score) and final scores as percentage of 22 maximum possible
points. Spearman’s r coefficient was used to assess correlations between total scores
and gender, ethnicity, and education level, respectively, to look for potential associations
informed consent understanding.
The survey asked providers what a patient should be expected to score on a test
that measured patient understanding and appreciation of the risks and benefits of CC to
then allow providers to conclude that patients had sufficient capacity to provide informed
consent for CC. The initial version of this item asked how many questions correct out of
11 (the number of items on the C4 instrument). Based on provider feedback, this item
was converted to ask for the “percent correct” response on the C4 assessment to qualify
for patients to be considered having informed consent capacity. For providers that had
previously answered out of 11, scores for this item were converted this to a percentage.
A frequency histogram of the responses was used to determine a reasonable estimation
of provider expectations of patient scoring. The minimum accepted score thus
determined was compared with actual performance of patients, scored as mentioned
above. Comparison to actual patient responses to analogous items was done with
frequency counts for provider answers to the following survey items: main reason for
CC, most common serious harmful effect, most serious harmful effects, medically
concerning symptoms following procedure, diagnostic alternatives, and treatment
alternatives. Because these questions were open-ended, providers may have listed
multiple responses for each item.
The survey also asked providers to rate the ethicalness (on a 0-10 scale, 0 = not
ethical at all and 10 = completely ethical) of applying pressure in the context of a patient
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initially refusing CC, for whom the provider felt the patient would be best diagnosed or
treated by CC. The survey asked this question in three scenarios: provider applying
pressure to patient, family applying pressure to patient, and provider applying pressure
to family. The initial version of the survey lacked the item concerning ethicalness of
provider applying pressure to family, which was added after initial interviews highlighted
the role of family in difficult situations. Descriptive statistics for these responses were
calculated. Because the same provider rated the items on a single given survey, this
violated the assumption of independence across samples, and answers to each of the
items was compared using repeated measures analysis of variance (ANOVA). Based on
Cohen’s method (35) with data from the ANOVA table, η2 was calculated as a measure
of effect size for item and provider on the ethicalness score. Following repeated ANOVA,
Tukey’s honestly significant difference (HSD) test for repeated comparisons was used in
determining whether the ratings for the three categories were significantly different from
one another (family-wise α=0.05). Further, I calculated correlations between these
answers and the following: fellow/attending status, number of consent procedures for CC
in career, and number of consent procedures for CC in the past year. Spearman’s rank
correlation coefficients were calculated for all correlations because of the limited sample
size and presumption of nonnormal data.
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Results
Participant Characteristics
Patient and provider sample characteristics are shown in Table 1. Patient
characteristics largely fit the state demographics, with 87.5% of patients obtaining a high
school or equivalent education (25% with a bachelor’s degree or higher). The patient
sample represented gender and ethnicity equally. One provider abstained from the
following survey items: level (fellow or attending), gender, and years in practice. A total
of 21 providers responded to the survey, representing a response rate of 68%. Providers
were split between fellows (52%) and attendings (43%). Women represented 19% of
respondents (men 76%). Attendings were involved in a lower average number of
consent processes in the previous year, but more over the course of their career.
Attendings indicated spending 3-30 years in practice, averaging 14 years.
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Table 1. Participating Patient and Provider Sample Characteristics.
PATIENT (n=8) Characteristics
Ethnicity
Hispanic
White, non-Hispanic

f

%

4
4

50
50

Gender
Woman
Man

4
4

50
50

Education
Less than high school equivalent
High school or equivalent
Associate’s degree
Bachelor’s or Professional degree

1
4
1
2

13
50
13
25

3
4

38
50

1

13

Mean
54.9

Range
33-70

f

%

11
9
1

52
43
5

Indication for procedure
Chest pain
Preoperative coronary angiography
prior to aortic valve replacement
Falls/syncope
Age in years
Average
PROVIDER (survey) (n=21) Characteristics
Level
Fellow
Attending
Not reported
Gender
Woman
Man
Not reported
Number of Consent Procedures*
Overall
Previous year
Career
Fellow
Previous year
Career
Attending
Previous year
Career*

4 (19%)

19

16 (76%)
1 (5%)

76
5

Mean

IQR

101
974

35-140
163-1000

117
198

70-175
130-250

81
1922

12-50
400-6000

Mean
Years in Practice

14

Range
3-30

*Career numbers rounded to number given, e.g., “>1000” rounded to 1000 for calculation of mean
and range.
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Measurements of Patient Understanding and Appreciation
The distribution of patient answers for the C4 instrument is shown in Table 2.
Responses to items 6 (description of what the provider will actually do) and item 10 (next
steps in the procedure) were open-ended and answers are listed separately in Table 3
and Table 4. Patient summary statistics for correct responses to the 11 C4 items are
listed in Table 5. The average score among all patients was 13.75 (63%) (maximum
possible score = 22). The highest score was 20 (91%), and the lowest 7 (32%). Initial
inter-rater agreement by weighted κ averaged across the 11 C4 assessment items was
moderate (κ = 0.64), with a high correlation between the two ratings (r = 0.73).
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Table 2. Distribution of Patient Responses for the C4 Consent Assessment.
Patient Responses
Item 1: Symptoms
Chest pain/discomfort
Syncope/pre-syncope
Preoperative for valve replacement
(no symptoms given)
Shortness of breath
Item 2: Purpose
Look for blockage*
Look at/check heart valve or pressures
Prevent heart attack
See damage to heart
I don’t know
Item 3: Main reason
Diagnosis
Find out where blockages are
Examine valve
Treatment (“to save my life”)
Item 4: Have to have if not want
Yes
No
I don’t know
Item 5: Alternatives (diagnosis or treatment)
I don’t know
Ultrasounds
Item 7: Risks*
Death
Stroke
Heart attack
Reaction to dye
Blood clot
I don’t know
Item 8: Benefits
Symptom relief
†
Information
Open blockage
Save life
I don’t know
Item 9: Possible not to be helped
No
Yes
Information either way
I don’t know/don't understand
Item 11: Post-procedure symptoms*
Chest pain/heart attack
Access site (bleeding, swelling)
Stroke symptoms
Fever/infection
I don’t know
Shortness of breath
Blood clot
High blood pressure

* Some patients gave >1 answer.
†
Both valve patients.

f

%

3
3
2

38
38
25

1

13

4
2
1
1
1

50
25
13
13
13

6
1
1

75
13
13

4
2
2

50
25
25

7
1

88
13

5
4
4
1
2
1

63
50
50
13
25
13

3
2
1
1
1

38
25
13
13
13

1
2
4
1

13
25
50
13

3
3
2
2
2
1
1
1

38
38
25
25
25
13
13
13

18
Table 3. Patient responses to item 6: “Please describe what your doctor will actually do
when he or she performs the catheterization.”
Patient
1

Response
SUBJECT: Well, she said they'll probably go in the wrist or the groin. And... the catheter... just
look. As far as I know that's it. I don't know, I'm not familiar with it.
INTERVIEWER: That's ok. Any other parts of the process that was explained?
SUBJECT: I don't know.

2

Well... When they go, whether through the groin or the wrist, they, you know, they gonna see, you
know, if there's any blockage, you know, they, they, they probably see--they will see all the other
stents to see if they're working. If there's any blockage in them, you know. Things like that.

3

SUBJECT: Well, I think, I think they, before putting they put stents on my legs, and, uh, and I
want--they want to put me to sleep, I guess. I mean, anesthesia. And, uh, they want to inject that
thing through my groin up to, what do you call it, a catheter, I guess? And put the wire in there
with a camera, I guess, with the arteries up into my heart. And inject some dye and check it out
and see what's going on there.
INTERVIEWER: Ok
SUBJECT: And I don't know if they're going to go down my legs or not, for that part. I don't know if
they're going to do that or not. Basically, I guess that's it.

4

Um, they'll be sticking a, uh, tube or a camera or whatever, into my--a tube into my main artery.
Um, and putting dye into my heart so they can see how my heart is functioning on the screen.
SUBJECT: Um, well, we just talked about that. They're going to go... put an IV in a vein and an
artery. And then they'll run a... thin wire in... and, uh, I'll be under x-ray. And they'll then check dye,
and they will... look at the arteries and veins and see for narrowing. Um, then, I don't know how
they're going to do it, but they said they'll take the pressures, look at the valve and take pressures
in the heart and everything. So I assume that little wire has a, it's connected to instruments
[laughs].
INTERVIEWER: Ok.
SUBJECT: Probably a lot more technical than I did. But they want to look under x-ray, look at the
dye to see if the arteries and veins are narrowed. Um... and get a better picture of the v--of the
valve, how well it's working, and the pressures, and... I'm sure that y'all have charts that you go by
and know exactly how good everything's going from getting all those readings.
He's going to put a... a tube, tinier than this one he said, into my leg. Well first they said in my arm,
then they thought my leg was better. And then they're going to go up, and I'm going to feel a hot...
flash or something. 'Til they get to wherever the blockage is.
Uh, I guess he's going into the groin, into the main artery, and they go in with a camera, and they
use dye, uh, contrast that helps them, I guess, guide the camera to my heart, through the, through
the main artery in my groin.
SUBJECT: From what I understand, they do a dye.
INTERVIEWER: Mmhmm.
SUBJECT: That shows that, if there's a blockage, any blockage.
INTERVIEWER: Ok. Um, so they use dye to see whether or not there's any blockages.
SUBJECT: Mmhmm, and god forbid there is, and they take care of that, fix it.

5

6
7
8
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Table 4. Patient responses to item 10: “If the results show you have blockage in an
artery, what might be the next steps in your treatment?”
Patient
1
2
3*
4
5*
6*
7*
8

Response
Whatever the doctor says [laughs]. I don't know. I don't know if it's surgery or not. I don't know all
the steps to this.
Well, they could, they gonna put in a stent. Yeah.
Well got back, I guess, and get a stent put in or something.
They'll probably put a stent in.
Well, I guess, let's see, uh. I... That's up to the, you know, the doctors, but, uh, you know, there's
always stents, uh... But more'n likely it'll be bypass surgery whenever they do the valve. When
they do the valve they'll do bypass surgery. Just get it taken care of right then.
Well they said if there is a blockage, they have to put a heart bypass.
Well, I, uh, they said if there's a blockage then, and let them choose to try to do a stent. And if
they can't fix it, if they didn't, then they would have to do bypass.
Well, a stent.

*Catheterization prior to aortic valve replacement, in which case “blockages” would be
treated by coronary artery bypass grafting and not stent placement.
Table 5. Patient (n = 8) Summary Statistics for the C4 Informed Consent Assessment
Instrument.
Cardiac Catheterization
Consent Assessment Question *
1. Symptoms you have for CC procedure
2. What doctor is trying to do with CC
3. Main reason doctor to perform CC
4. Do you have to have CC if you do not want
5. What are alternatives to having CC
6. What will doctor actually do when doing CC
7. Describe seriously harmful things could happen
8. Describe some ways you could be helped w/ CC
9. Possible your will not be helped by having CC
10. If artery blocked, what would be next steps
11. Post CC, for what symptoms should you call
Total Score **

%
Incorrect
0
25.0
12.5
62.5
87.5
0
12.5
25
0
12.5
25

%
Partly
Correct
25.0
37.5
25.0
12.5
0
50.0
50.0
0
50.0
12.5
37.5

%
Correct
75.0
37.5
62.5
25.0
12.5
50.0
37.5
75.0
50.0
75.0
37.5

Mean (SD)
Score
1.75 (0.46)
1.13 (0.83)
1.50 (0.76)
0.63 (0.92)
0.25 (0.71)
1.50 (0.93)
1.25 (0.71)
1.50 (0.93)
1.50 (0.53)
1.63 (0.74)
1.13 (0.83)

23.9

27.2

48.9

13.75 (4.26)

* All questions scored 0 = fully incorrect; 1 = partly correct; 2 = fully correct.
See Figure 1 for fully worded questions.
** Total percent correct represents overall percent out of 22 possible points (SD).
Correlations of C4 Items with C4 Total Score and Subscale scores are in Table
6. Of these, most (9 of 11) items showed acceptable associations (0.38 ≤ r ≤ 0.79) with
the overall 11 item score. Item 11 (concerning symptoms following procedure) was
negatively correlated with both appreciation and reasoning subscales and C4 total score,
and it was only lowly correlated with the understanding subscale. Item 3 (main reason
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for your doctor to perform the catheterization) was correlated acceptably with the
appreciation and understanding subscales but essentially not at all with the reasoning
subscale and the overall score. However, one problem with the reasoning subscale is
that is only a single item, and single items are well-known to typically have low reliability
(36). Thus, correlations with the reasoning item are not necessarily good estimates of
population values for this reason, which is compounded by the fact that the sample size
is only 8 patients.
Calculation of Cronbach’s α for the domains (Table 7) showed an acceptable
level of internal consistency for measurements of understanding, and good consistency
for appreciation (reasoning only had one item measuring the domain). Correlations for
patient characteristics and total score are shown in Table 8. Of these, gender showed a
very strong correlation with total score (r = 0.82), more so than education, ethnicity or
age. Gender and education were modestly correlated (r = 0.47), but all women had a
high school or equivalent education, and men represented both extremes of educational
attainment (less than high school and bachelor’s/professional degree).
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Table 6. Correlations of C4 Consent Assessment Items with C4 Total Score and C4
Subscales.
Domain

C4 Assessment
Question *

Understanding

1. Symptoms you have
for CC procedure
3. Main reason doctor to
perform CC
7. Describe seriously
harmful things could
happen
8. Describe some ways
you could be helped w/
CC
11. Post CC, for what
symptoms should you
call
4. Do you have to have
CC if you do not want
5. What are alternatives
to having CC
6. What will doctor
actually do when doing
CC
9. Possible your will not
be helped by having CC
10. If artery blocked,
what would be next
steps
2. What doctor is trying
to do with CC

Appreciation

Reasoning

*p<0.05

†

C4
Total
score

Understanding

Appreciation

Reasoning

0.44

0.53

0.45

0.47

0.13

0.41

0.76*

-0.01

0.72*

0.61

0.69

0.47

0.76*

0.78*

0.70

0.47

-0.38

0.27

-0.45

-0.65

0.79*

0.13

0.79*

0.87

0.58

0.51

0.58

0.44

0.66

0.51

0.66

0.46

0.82*

0.28

0.83*

0.81*

0.49

0.31

0.50

0.50

†

0.12

†

1.00

0.89

0.92

p<0.01

Table 7. Internal Consistency of Total Score and Multi-item Subscales.
Domain
Understanding
Appreciation
Total 11-item Score

Cronbach’s α
0.66
0.76
0.83

Table 8. Correlations Among Patient Characteristics and C4 Total Score.
Characteristic
Education
Gender
Ethnicity
Age
*p<0.05

Total score Education
0.39
-0.82*
0.47
-0.05
0.29
-0.39
-0.31

†
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Patients rated their own understanding of CC on a scale from 0 = no
understanding to 5 = moderate understanding to 10 = complete understanding). A
comparison of patient self-rating their own understanding of CC and C4 scores for
patients is shown in Table 9. To facilitate comparison, C4 scores are shown as percent
correct, and patient self-ratings on the 0-10 scale were converted to a 0-100 scale to
facilitate direct comparison to the % correct scale for C4 objective scoring.
A moderate but not significant correlation (r = 0.37, p = 0.37) between patient
self-scored understanding of CC and objective C4 score was found. A paired t-test of the
mean self-score vs. objective C4 scores revealed that self-score was significantly higher
than C4 score (t (7) = 2.88, p = 0.02; Cohen’s d = 1.16).
Table 9. Comparison of Patient Self-ratings of CC Understanding with Objective C4
Scores for Understanding CC.
Patient
1
2
3
4
5
6
7
8

Self-score C4 Score (%)
50
32
90
68
90
64
100
64
70
82
85
41
85
91
95
59

Difference
18
22
26
36
-12
44
-6
36

r = 0.37, p = 0.37
Means*
(SD)

83.13
(16.02)

62.62
(19.39)

20.50
(20.11)

*Cohen’s d = 1.16, p < 0.02
Patient Semi-structured Interview
The themes resulting from qualitative analysis of the patient interviews are listed in the
Table 10. Interviews with patients were ended after determining that thematic saturation
had been reached.
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Table 10. Themes from Patient Interviews (N = 8).
Theme
Communication
Decision-making

Feelings

Handling difficult situations
Purpose of consent discussion

Suggestions for improvement

Codes
Communication difficulties
Good communication
Jargon use by doctors
Family involvement
Freedom to decide
Got to have it done
Internet/prior reading
Not really want procedure
Pressure by others
Prior experience/knowledge
Trust in provider
Discomfort
Fear/anxiety
Return to normalcy
Unfamiliarity/uncertainty
Physician emphasis of importance
Physician obligation to patients
Trust in provider
Calming
Information
Legal
Make sure patient wanted procedure
Better communication
More information beforehand
Visual aids

Communication did not emerge as a strong theme. Only one patient expressed
communication difficulties with healthcare providers, and this mainly related to believing
he received contradictory messages concerning the procedure. (This patient went for
evaluation of CAD prior to valve surgery to see if bypass grafting would be performed
with valve replacement.)
“[The first provider] told us they might put the stents in. And the doctor said they won't do
that today. But it was pretty--there was something contradictory, you know?” (Hispanic
man, 64 years old)
On the other hand, more patients mentioned good communication.
“He didn't try to use highly technical terms. And, uh, so uh, he did a very good job to try
to make sure I knew what was going on.” (non-Hispanic white man, 52 years old)
“He talked in language, uh, at my, my... education level or... medical education, I should
say, you know?” (non-Hispanic white man, 52 years old)
“Well this one explained, I think, good.” (Hispanic woman, 70 years old)
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One patient in particular noted the use of medical jargon by providers in explaining CC:
“And I think that's a lot of the problem, they don't explain it in English… They always
throw in, it's a mixture of English and ‘doctor.’” (non-Hispanic white woman, 53 years old)
Decision-making was a common theme in patient interviews, with several
components. Regarding making the decision, however, few had done prior reading or
Internet searching or had prior firsthand experience. A significant aspect of decisionmaking, which also overlapped with handling difficult situations, was trust in providers.
Patients were explicitly asked: “Did you feel like you had a choice in deciding to be
catheterized, or did you just go along with what the doctor recommended?” All patients
indicated that they felt free to decide for themselves whether or not to undergo CC.
“I mean, you can refuse any kind of treatment from a hospital. I mean, damn right, you
know, which I have before.” (non-Hispanic white woman, 53 years old).
However, even in stating they felt free to make their own decision regarding CC,
most patients also said they “just went along with the doctor.”
“I went along with my doctor, but I did tell her I was afraid to have it done.” (Hispanic
woman, 50 years old)
“I just went along with it. They said they want to, and I said ‘ok.’” (non-Hispanic white
woman, 53 years old)
“I mean, the doctor recommended it, and I went along with it.” (non-Hispanic white man,
70 years old)
“The doctors know what's going on, so I'll go with that their opinion is. I’d trust the
doctors.” (Hispanic man, 33 years old)
“I think that they know better than I do what's going on the heart…And I took their advice
and here I am.” (Hispanic man, 64 years old)
Several patients highlighted family involvement in the decision-making process,
either directly or indirectly.
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“[M]y family, all them insisted that I go through it to know... where the blockage, or
whatever is wrong with my heart, or the artery, because they're afraid I might have a
heart attack or something.” (Hispanic woman, 70 years old)
“Well, my family, yes. They said, ‘if you need it done, get it done so you can feel better.’”
(Hispanic woman, 50 years old)
“I have my family with me, and they support me with it.” (non-Hispanic white woman, 50
years old)
Although all patients explicitly denied feeling as though providers pressured
them, several indicated family pressure played a role in the decision to undergo CC:
“They're the ones putting pressure on me. The doctors didn't. The two girls.” (nonHispanic white man, 52 years old)
“But my family are the ones that say, ‘No, Mom, go through with it, go through with it.’”
(Hispanic woman, 70 years old)
“My wife and kids, they’re pushing me to do it.” (Hispanic man, 64 years old)
Another component under the decision-making theme appeared to be that
patients felt as though they had to have the procedure, for one reason or another (i.e.,
that there were not viable alternatives). This often went hand-in-hand with expressions of
not really wanting the procedure, but not always. The latter primarily overlapped with
family pressure mentioned above.
“How can I go on with those pains? I got to have it done, yeah.” (non-Hispanic white
man, 70 years old)
“I know I have to have [cardiac catheterization].” (Hispanic man, 64 years old)
“They know about the risk. I, and I gotta have the procedure anyway.” (non-Hispanic
white man, 52 years old)
“I'd rather them have a better look at my heart than not, you know? Yeah, so I think that
it's a positive procedure prior to going into open heart surgery.” (Hispanic man, 33 years
old)
“If there are alternatives, I'd probably do that, because I don't want to do this. [laughs]”
(non-Hispanic white woman, 47 years old)
“I didn't want it, to tell you the truth, because I feel ok.” (Hispanic woman, 70 years old)
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Patient feelings were also a significant theme during the interviews, and some
degree of patient unfamiliarity/uncertainty was common among the codes, with five of
eight patients (62.5%) expressing this emotion.
“Well, she said they'll probably go in the wrist or the groin. And... the catheter... just look.
As far as I know that's it. I don't know, I'm not familiar with it.” (non-Hispanic white
woman, 53 years old)
“I don't know [laughs]. I'm not a doctor so I don't know [laughs].” (non-Hispanic white
woman, 53 years old)
“I don't know anything about my heart.” (Hispanic man, 64 years old)
“I probably should have questions, but probably my ignorance, or lack of knowledge, I
should say, of medical procedures keep me from asking more questions.” (non-Hispanic
white man, 52 years old)
“Well, to tell you, like I said, I don't know what this is. And I can't explain what to expect.”
(Hispanic woman, 70 years old)
Patients also discussed fear and/or anxiety related to either the procedure itself,
or the situations leading up to the procedure.
“Because to be left in a room, scared like that, it just builds up more fear and make the
problem worse.” (non-Hispanic white woman, 53 years old)
“And be where [I’m] fearful for passing out again somewhere else.” (Hispanic man, 64
years old)
“I went along with my doctor, but I did tell her I was afraid to have it done.” (Hispanic
woman, 50 years old)
Two patients mentioned the hope for future symptom relief, in the form of a return
to normalcy, which often influenced decision-making.
“I want to be able to do what I was doing, you know?” (non-Hispanic white man, 70 years
old)
“[I want to] get back to my normal life again.” (Hispanic man, 64 years old)
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Regarding the purpose of the informed consent discussion and process, nearly
all patients (7 of 8, 87.5%) stated that it was for the provision of information about the
procedure to the patient.
“That they were letting me know what's going on, to happen, there, you know? That.”
(Hispanic woman, 50 years old)
“For me to know what they're gonna do.” (Hispanic woman, 70 years old)
“To make sure that I really understood what was going on. Understood the risks. Um,
and, was ready to, to go ahead with it.” (non-Hispanic white man, 52 years old)
“To give me more knowledge.” (non-Hispanic white woman, 53 years old)
Only one patient thought the purpose of the discussion was legal (“Liabilities, I
imagine,” Hispanic man, 64 years old). Two patients also said the purpose of the
discussion was to ensure patient willingness to proceed with the procedure (“was ready
to, to go ahead with it,” non-Hispanic white man, 52 years old).
Patients were given the following scenario, and asked for responses:
“Imagine you were in an emergency situation, and a provider thought that
a given procedure would potentially be life-saving in your specific
situation. You completely understood everything the provider said as far
as benefits of the procedure, risks of the procedure, and so forth, but, for
whatever reason, you said that you didn’t want the procedure to be done.
How OK is it, or is it OK at all, for the provider to apply pressure to you in
order to get you to change your mind and let them do the procedure?”
Patient responses to this scenario, under the theme of handling difficult
situations, fit under three main areas: physician emphasis of importance, physician
obligation, and trust in providers.
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“Yeah, he, he would have to be... put pressure on then to have it done. Just so that he
could, not-- to be clear with everyone that he did everything he could. I can't make 'em
do it, but I tried. I did the best I could to make him, absolute clear to him, ‘you'd be a
dead man if you don't.’” (non-Hispanic man, 52 years old)
“And if it's a dangerous situation, then just be real with me, and, you know, how
dangerous it is. If it's life-threatening or not. Or if I could go without it and then be fine or
not.” (Hispanic man, 33 years old)
“Well, I would appreciate them, I really would, explaining to me why it was, like, ‘you
have to have this or you're gonna die.’” (Hispanic woman, 50 years old)
Interestingly, all patients (100%) expressed that providers should place pressure
on patients in such a scenario, even invoking the Hippocratic oath:
“If the doctor thinks there's concern it might kill me, then yeah, they should put on
pressure to save a life.” (non-Hispanic white woman, 53 years old)
“They take an oath for that. You know? And it kills them to lose a patient, I know that.”
(non-Hispanic white woman, 53 years old)
“That's the oath that they took and all in becoming a doctor. To help people.” (nonHispanic white man, 70 years old)
“I do believe they need to push the issue if it's a life-saving measure and you're not
willing to do it.” (non-Hispanic white woman, 47 years old)
“Yeah, he, he would have to be... put pressure on then to have it done. Just so that he
could, not-- to be clear with everyone that he did everything he could. I can't make 'em
do it, but I tried. I did the best I could to make him, absolute clear to him, ‘you'd be a
dead man if you don't.’” (non-Hispanic white man, 52 years old)
“[If] he firmly believes, he's obligated. Just for his own peace of mind.” (non-Hispanic
white man, 52 years old)
“I think that if something's going on, do everything you can.” (Hispanic woman, 50 years
old)
“And if it's a really, really bad, and they really, really think it's something that needs to be
done, then they should, like, try to encourage me, at least let me know” (Hispanic man,
33 years old)
Trust in providers emerged as a theme in relation to both difficult situations (as
the scenario above), as well as in the decision-making process for undergoing the
present CC.
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“Because if they have concerns then I should be concerned, because they're the ones
that are knowledgeable about the medical field, not me.” (non-Hispanic white woman, 53
years old)
“I think that they know better than I do what's going on the heart.“ (Hispanic man, 64
years old)
“The doctors know what's going on, so I'll go with that their opinion is.” (Hispanic man,
33 years old)
Only a few patients made suggestions regarding improvement in the informed
consent process, and their suggestions were: better communication (less jargon), more
information beforehand, and using visual aids.
Provider Survey Data
The distribution of item responses for the provider is shown in Table 11. One
respondent in the provider survey abstained from the following items: estimated
probability of death due to CC, number of consent processes in the previous year and
career, level (fellow or attending), gender, and years in practice. A different provider
chose not to answer item 2 (most common harmful effects), but answered the other
items listed.
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Table 11. Provider (N=21) Survey Responses.
Provider Responses*
Total respondents

f
21

%

12
4
2

57
19
10

12
1

57
4.8

Item 2: Most common harmful effects
Bleeding/hematoma/vascular access
Renal damage
“Psychological stressor”

16
3
1

76
15
5

Item 3: Most serious harmful effect
Stroke/embolic event
Bleeding
Renal damage
Myocardial infarction
Death
Vascular
Medication reaction (including dye)
Emergent surgery (including tamponade)
Infection
Radiation damage
In-stent restenosis

19
15
15
10
10
6
4
3
2
2
1

90
71
71
48
48
29
19
14
10
10
5

Item 1: Main reason
Diagnostic
Diagnose CAD
Positive stress test
Cardiomyopathy
Therapeutic
Chest pain/acute coronary syndrome
Explicitly for symptom relief
†

‡

Item 5: Post CC concerning symptoms
Access site (e.g., bruising, bleeding, pain, swelling)
Chest pain or recurrent symptoms
Shortness of breath
Not urinating
Back pain
Fever/chills
Hives/allergic reaction
Nausea/vomiting
Hypotension
Neurologic symptoms
“Stroke symptoms”
Syncope/light-headed
“Neuro dysfunction”
Altered mental status
Numbness/tingling

29
18
8
3
3
2
1
1
1
9
3
3
2
2

Item 6: Diagnostic alternatives
Non-invasive imaging without stress
Coronary angiography via computed tomography
Stress testing (treadmill, echocardiography, nuclear)
Empiric medical management

12
10
17
4

Item 7: Treatment alternatives
Medical management
Exercise/lifestyle modification
Surgery

21
2
2

* Providers were able to provide ≥1 response.
†
One provider did not answer item regarding most common harmful effects.
‡
Frequency only is shown because of overlapping answers given by the same provider
(e.g., both bleeding and bruising listed as separate answers)
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In item 4 of the survey, providers answered the following question:
“If a patient was tested on his or her understanding of basic cardiac
catheterization procedures and his or her appreciation of the related risks
and benefits, what percent correct of informed consent-related questions
should the patient answer correctly to be considered able to consent for
the procedure?” [Underlines for emphasis included in the original survey.]
A frequency histogram of provider responses is shown in Figure 2. The mean
percent correct was 79.1% (standard deviation 20.5, range 27-100%). Seventeen of 21
(81%) providers responded that the minimum percent correct in order to consent was
70% or higher.
Figure 2. Frequency Distribution of Provider Estimates of Percent Correct Questions
that a Patient Must Answer to be Considered to have Capacity to Provide Consent for
Cardiac Catheterization.

Items 8, 9, and 10 of the provider survey asked about the ethics of applying
pressure in difficult situations on a 0-10 scale. Item 8 asked how ethical it was for
providers to apply pressure to patients, item 9 about family applying pressure to patients,
and item 9 about providers applying pressure to families. Summary statistics of these
items are shown in Table 12.
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Table 12. Mean (SD) Responses to Provider Questions Asking about Applying Pressure
to Patients to Consent to Cardiac Catheterization.
Item
N Mean* SD
Provider to apply pressure to patient 21
5.24 3.53
Family to apply pressure to patient
18
5.94 3.28
Provider to apply pressure to family 21
3.29 3.78
*Higher mean values indicate greater ethical acceptability
*Maximum Cohen’s d = 0.76
The means were subjected to a repeated measures ANOVA to compare the 3
items rating ethics of applying pressure to patients or family members by providers or by
family members(see Table 13). The item itself had a modest effect on the score (η2 =
0.078), representing providers as a whole may view these scenarios as different.
Table 13. Repeated Measures ANOVA Summary Table Comparing Mean Ratings of 3
Items Regarding Target (Patient vs. Family Member) of Pressure and Source (Provider
vs. Family Member) of Providing Pressure on Patients to Consent to Cardiac
Catheterization.
Effect
Question
Provider
Model
Error
Total

Partial SS
62.26
569.29
644.99
149.74
794.73	
  

df
F
2 7.69
20 7.03
22 7.24
37
59	
  

p
0.002
<0.001
<0.001

η2
0.08
0.72

Multiple comparisons among item ratings using Tukey’s HSD post hoc tests are
in Table 14. These show that mean ethical rating between the scenarios of provider
applying pressure to patient is not significantly different from the ethical rating of family
applying pressure to patient in order to convince a patient to have a procedure that the
patient initially refused. However, providers consistently rated as less ethical the
scenario of providers applying pressure to family members in order for patients to
change their minds; this difference in rating was statistically significant both in
comparison to the ethicalness of providers applying pressure directly to patients and
family applying pressure directly to patients.
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Table 14. Pairwise Contrasts Among the Items Rating the Ethics of Scenarios of
Applying Pressure to Patients for Consenting to Cardiac Catheterization
Contrast

Means
(pooled SD = 3.51)

Mean difference

Cohen’s d

HSD t

Prov-pt vs Fam-pt

5.24

5.94

0.71

0.20

1.57

Prov-pt vs. Prov-fam

5.24

3.29

1.95

0.55

4.33*

Fam-pt vs. Prov-fam

5.94

3.29

2.66

0.76

5.89

†

Prov-pt = provider pressures patient
Fam-pt = family pressures patient
Prov-fam = provider pressures family
†
*p=0.01
p=0.001

Intercorrelations between the provider estimation of percent correct responses on
a test of understanding and appreciation for a patient to be able to provide consent for
CC, the number of consent processes performed in the provider’s career and previous
year, and the level of training (fellow or attending) are reported in Table 15. The number
of consent processes conducted in the provider’s career was correlated with the rated
percent correct needed (r = 0.53), as did the provider level of training (r = 0.41), both
indicating that attendings and more consent experienced providers expected patients to
be able to answer more questions correctly to allow providing consent than did fellows or
less experienced providers. The number of consent processes performed in the past
year had a negative correlation with level of training (r = -0.52), indicating that fellows
tend to perform more discussions in the previous year than attendings. This discrepancy
may help explain the difference in correlation between expected percent correct between
number of career discussions (r = 0.53), which may be more representative of attending
views, and number of discussions in the past year (r = 0.07), which may represent the
influence of fellow views.
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Table 15. Intercorrelations Between Provider Rated Needed % Correct Responses on
Consent Assessment Questions and Level of Provider Consent Experience and Level of
Provider Training.
Measure

% Correct to
Consent
0.53
0.07
0.41

Career consent processes
Consent processes last year
Level of training *

Career
--0.31
0.85

Last
Year
--0.52

*0 = fellow or 1 = attending; negative indicates more closely correlated with fellows
Provider Semi-structured Interview
Themes observed from the provider interviews are listed in Table 16.
Table 16. Themes from Provider Interviews.
Theme
Challenges

Expectations of patients

Feelings
Examining patient point of view

Pitfalls of informed consent
Purpose of informed consent
Technique

Codes
Applying pressure
Emergent situations
Refusing a procedure
Time pressure
Ask questions
Acknowledge right of refusal
Be part of decision-making process
Interest (in own health)
Try not to expect much of patient
Voice discomfort/not understanding
Discomfort
Superstition
Confusion
Legal purpose
Patient expectations of providers
Patient fear/anxiety
Presumed to want treatment if sick
Trust in provider
Information overload
(Over)focusing on risks
Using jargon
Medico-legal/pro forma
Patient autonomy/patient decision-making
Providing information
Big picture
Empathy/understanding patient views
Gauging patient
Give time as possible
Have patient explain
I ask questions
Imagery
Plain language
Role of family
Tailoring to patient/scenario

35
Providers described their formative impressions of the informed consent process
as during late medical school or during their intern year. All but one provider (86%) noted
that the first exposure was practical, rather than a formalized lecture or didactics.
“Not...No formal, uh... No. It was sort of ‘go consent Mr. S for a procedure.’ Why? Some
of the better residents, I think, did have me tag along when they would be doing that, but
it certainly wasn't universal. It was never part of my training where I was actually taught
how to obtain informed consent.” (Fellow)
“I think I watched [as an intern], I was following my resident for one of them, then I
started doing them by myself.” (Fellow)
“But probably going in and anticipating doing or assisting with a procedure, an LP or a
paracentesis. Ah, my intern or resident would tell me we need to do an informed consent
and I would watch them do it.” (Attending)
Commonly, providers described their initial impression of the purpose of informed
consent as either medico-legal or pro forma in nature, but some also described an initial
understanding of using the process as a method for information delivery.
“I felt like it was mostly legal… if something goes wrong, you agree to it, so it won’t be
my fault kind of thing.” (Fellow)
“Focus was on you have to have a signature, a witness, a form. Or that was at least my
feeling as a… junior medical student…[The] drive behind talking about an informed
consent was driven, was sort of medico-legal.” (Fellow)
“So it was explained to me as trying to get the patient to agree to do the procedure. And
it’s mainly trying to explain to them what we want to do.” (Fellow)
“[The purpose] is that the patient should know what they’re signing up for. Know the risks
and benefits and be able to decide after hearing from the person that’s going to do the
procedure if they want to go through with it.” (Attending)
“[The purpose is] so the patients can have as much, I guess, information to allay their
fears, concerns, etc., in that peri-procedural period.” (Attending)
Most providers indicated that they were uncomfortable during their first attempts
at obtaining informed consent for procedures, driven in varying degrees by concern
about lack of knowledge, or even guilt regarding a perceived lack of transparency in not
explaining their newness as a trainee to patients.
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“I never felt comfortable [when getting a consent from a patient].” (Fellow)
“I do remember a vague sense of dread.” (Fellow)
“I think at least [during] those initial ones, there was certainly some anxiety.” (Attending)
“I think I was bringing a lot of my ‘hey, I’m a first-timer,” and I never disclosed that to my
patients. And I also felt guilty about that.” (Fellow)
Providers who had several years’ experience in obtaining consent for
interventions and reported being more comfortable in their role, described a more
nuanced purpose of the informed consent discussion. Fellows and attendings gave less
attention to potential medico-legal reasons, but more emphasis on patient-centric ideals,
such as providing information and allowing patient autonomy.
“I think now is to make sure that the patient, in broad terms, they know what their getting
into. They know what to expect. Not just what to expect with the procedure. First we're
going to be doing this. Next we're going to be doing that. But really understanding...why I
think this procedure would be a good thing, certainly if we're recommending it to them.
Um, as well as making sure they understand what the potential risks are. Not only, not
only why we're doing it or why we think this is important, but what are the potential bad
things that can happen. Make sure that they understand, specific to them, these are the
things that might go wrong. What are the chances that's going to go wrong? And make
sure they understand that there's always more than one way to do things. Make sure
they understand what the alternatives are.” (Attending)
“[The purpose] is that the patient should know what they're signing up for. Know the risks
and benefits and be able to decide after hearing from the person that's going to do the
procedure if they want to go through with it.” (Attending)
“It's to provide the patient with...an adequate level of information for them to at least
understand what a procedure involves, and why it's being recommended, and what
could go wrong.” (Fellow)
“I think informed consent, as it implies, the reason you get it is because you want to
make sure your patient really understands what is going to be done to them, and why.”
(Fellow)
“But I think overall is...um, patient autonomy and us...you know, uh, doing our job in
terms of telling them ‘this is what we recommend. Here are your options.’” (Fellow)
Despite this, providers also frequently depicted the consent process as a pro
forma maneuver. “As long as the [consent] form is signed” one may proceed with the
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procedure, suggesting low concern for actually gaining true informed consent from
patients. This attitude occurred more frequently in dealing with urgencies or
emergencies, in which providers believed the benefits of CC significantly outweighed the
risks.
“These are the benefits, these are the things that can go wrong. You have questions?
What do you think? You agree? Sign.” (Fellow)
“For a simple, straightforward, "Don't worry, you're risks are...I can't even see them,
they're so low. You, know, your benefits are up here. I can save your life. Save your
heart, it will go back to normal. You're going to go back to a normal life." I don't care if
the guy understands what a catheter is, or, you know, who cares? Let me just take care
of it. Sign right here, please.” (Fellow)
“But I think it depends on how indicated I think the procedure is. Somebody's coming in
with a STEMI, you know, and I think that I can really impact their life. Um... You know,
I'm probably going to take their face-value signature as consent.” (Attending)
However, providers described mixed attitudes regarding the application of
pressure on patients who had initially refused a procedure, even if the provider felt that
procedure would be potentially life-saving. Providers frequently dealt with this by
emphasizing the importance of the procedure, and by ensuring the patient gave a “hard
no” (which was not necessarily seen as applying pressure). Some providers also
described the role of having the patient’s family apply pressure in these circumstances.
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“You know, you don't, you try not to force something upon... that's not clear.” (Fellow)
“I don't think it's OK to put pressure on the patient.” (Fellow)
“I feel that it's really an abuse of our power to coerce people into doing something that
they're apprehensive of. You know, as a result I've, you know, I’ve sat on some STEMIs,
and I've watched people be medically managed through large MIs, and I've felt bad
about it throughout.” (Fellow)
“Pressure is, uh...meh...it's a difficult word, I think, to use in consenting process. Ah,
but... I have to think of what you're trying to say. Um...[sigh] I think that pressure would
equal...um... detailed explanation.” (Fellow)
“I think I would put a moderate amount of pressure, but not because I would pressure
them to say ‘yes,’ but because I just want to make sure that they understand what
they're saying no to. So I would say that I probably do put a little bit of pressure on
them.” (Attending)
“I make sure the family knows and the patient knows that the patient is the boss. And we
don't want to talk him into doing anything that he doesn't want to do. But they're
ultimately the ones that make that decision.” (Attending)
“If there's some dynamic there that a family member is able to convince a patient to do
something that I pretty firmly believe in, as long as the patient agrees, I would call that
consent.” (Attending)
“I've... resorted to family members, or I have not interfered with family members
pressuring patients.” (Fellow)
“Honestly, we did. We try to do that [apply pressure]. We try to, to talk to them in a heart
cath multiple times. It's, uh... I don't know if it's right or wrong, but in that situation when
your clear medical judgment is cath, I think it's probably appropriate to try to convince
the patient and show them, make sure they understand that they're probably making a
wrong decision in refusing a heart cath. Unless they have a clear, you know,
contraindication that's reasonable.” (Fellow)
These notions dovetail with the abbreviated process of informed consent in
emergent situations.
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“I think that the informed consent receives a little bit of short shrift in that situation,
because I think that, and this is probably a little paternalistic, but I think that I don't want
them perseverating over potential complications, including renal insufficiency, contrast
reaction, etc., because the risk of not opening up a proximal LAD is tremendous.”
(Fellow)
“I could care less about getting a signature. And say, "You're having a heart attack, we
need to take you to the cath lab right now, you're unstable. Can you sign here for me to
help you?" (Fellow)
“When we're consenting, um, in a STEMI situation, I literally spend about 4 minutes
doing in. I'm trying to do it as quickly as possible.” (Fellow)
Common shortcomings in the informed consent process, as depicted by
providers, included “information overload” for the patients, which also went with over
focusing on risks. This proved to be a uniform theme among providers. Most providers
felt they performed well in avoiding use of medical jargon in discussing medical issues
with patients, but they also acknowledged this as a potential cause for concern.
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“I would imagine that it's extraordinarily difficult for a patient to grapple even with a
relatively minor new diagnosis. And then, by the way, this minor new diagnosis means
you need to have a major or minor medical procedure, and the procedure can cause 27
things, including heart attack, stroke, death.” (Fellow)
“A lot. A lot. A great deal of information in a short period of time, especially in an urgent
situation. But, you know, ah, it's a lot of information.” (Fellow)
“They need to understand that I cannot give them the 100th possible side effect of a
medication or the 100th possible poor outcome of a procedure. There is just not enough
time in the year to be able to do that.” (Attending)
“You know, do I need to tell every single person when I have a wire in their artery, or in
their LV, they may have PVCs? You know, that's, I suspect that that's going to launch
into--if they're really interested--that's going to launch into a side discussion of the
importance of PVCs, right?” (Attending)
“Rate of information administration. If they're just...vomiting, uh, large amounts of, uh,
information, giving the patient way too much information to handle all at once.”
(Attending)
“I don't know that it helps them any to go through a laundry list of possible complications
that are very anatomic and very medical terminology-wise.” (Attending)
“So more information is probably not as helpful as repetition and trying to simplify our
message into a very concise thing that they could tell someone on the telephone in 3
minutes.” (Fellow)
“But I think that it is important to tell people what the potential benefits are. Because we
tend to get caught up in the all the risks, and I think that's why patients tend to think it's
more of a legal document than a consent.” (Attending)
Providers expressed expectations of the patient entering into the informed
consent discussion. Most providers expected the patient to at least show some level of
interest in the patient’s own health. Many also expected the patient to ask questions
during the process, and perhaps explicitly to acknowledge whether or not they
understood what was being discussed. Two providers stated that they did not expect
much of patients, in part because their experiences in previous consent situations had
been disappointing regarding patient efforts to be actively involved.
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“I think the most basic is that they will…listen, and be engaged. (Fellow)
“Some degree of interest. However minimal.” (Fellow)
“We expect people to be interested in what’s going on with them.” (Attending)
“I mean, I’m expecting the patient to ask questions… Um, and I’m expecting patients to
ask me about, uh, complications and alternatives.” (Fellow)
“I want them to be understanding [sic], and try to ask questions if they don’t understand
it.” (Fellow)
“They have the responsibility to ask questions or say ‘no, I don’t understand’ when I ask
them if they understand.” (Attending)
“I don’t expect them to [ask questions], just because a lot of the time they don’t.”
(Attending)
“I’m trying not to have expectations, because most of the time they’re just trashed
[laughs]. It’s like, yeah, well, I expect you to take your medications. I expect you to follow
things.” (Fellow)
Several providers described the technique they use in conducting the informed
consent discussion. Common areas including discussing the “big picture” of what is to
happen, asking questions of the patient and/or having the patient explain the procedure
(and risks, benefits, etc.). Imagery and plain language (not medical jargon) were
emphasized. Providers frequently depicted the ability to gauge patient understanding as
being integral to the process, with methods such as observing patient body language
(such as “just nodding along”), whether or not a patient asks questions at all, and
eliciting patient explanations of the procedure.
To ascertain issues from the patient’s point of view, providers outlined several
areas. Among these was asking a patient about their understanding of the purpose of
the informed consent discussion (information, legal) and the CC procedure itself. Other
points of emphasis by providers were: (1) the role of the provider in explaining CC and
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its risks and benefits well, (2) being sure always to have patient’s best interest in mind,
and (3) to carefully observe patients’ possible confusion and/or fear or anxiety.
“They feel it’s like, the doctors made the decision about what to do, or what’s best for
them, and they’re just getting information about what’s going to be done.” (Fellow)
“[He or she] feels that we’re just pretty much informing them that’s what needs to be
done.” (Fellow)
“To give them an idea of what to expect.” (Attending)
“Well, they just want me to sign this so I can’t do anything if I have a bad outcome.”
(Attending)
“But I think if I was a patient, I would wonder why they are doing this. If I need this, why
are they having me sign the piece of paper? It sounds like they’re trying to protect
themselves.” (Fellow)
“I think they perceive it as another thing that I have to sign.” (Attending)
“I would hope that patients’ expectation would be that the doctor would be interested,
compassionate, honest, and would convey the right amount of information for that
situations about why something is being done, what could happen, and what the benefit
would be.” (Fellow)
“The other side of it is for any heart procedure, or any medical procedure, I think patients
are at a huge disadvantage. They’re scared, they’re vulnerable, they’re ill.” (Fellow)
“Because sometimes they, you know, obviously it’s a chaotic time, they’re scared, they
may only hear just about complications.” (Attending)
Interestingly, some providers appeared to hold a somewhat superstitious outlook
on the informed consent process. The underlying notion is that conducting a poor
discussion, or taking a patient for a procedure who did not really understand or want it
(but nonetheless “signed the form”) may “set one up” to have a complication or bad
outcome.
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“Once you cross that line in which you're pulling [the patient into the procedure]...you
know it's not 100%, you know that person didn't feel that the wanted to do it, and you're
setting yourself up for bad outcomes.” (Fellow)
“But, you know, those are the patients that I really want to make sure [laughs] that they
want to do it. Because it seems like, coincidence or not, those are the patients that can
have problems, or seem like they more frequently have problems.” (Attending)
“Not necessarily that the patient is going to do poorly, because you might save that, you
know, myocardium, but the patient is not going to be happy with it. Um... Things are
going to come up, you know. Chest pain that's never going to go away and it was your
fault because you put that stent in there. So...I don't know. Again, it hasn't happened to
me very frequently because most people are just in need of getting something taken
care of right away and are just agreeable, but I can see a situation like that going real
bad.” (Fellow)
Comparing Provider and Patient Perspectives
When providers gave the minimum percent score acceptable for a patient to be
able to provide informed consent, over three-fourths (81%) gave 70% correct or above
as the cutoff. A patient scoring less than this may not be considered adequately
informed in order to provide the consent. Using 70% as the criterion, then, only two
patients (25%) met the providers’ level minimal acceptable level of understanding and
appreciation on the C4 instrument.
Most patients (88%) described a diagnostic purpose as the main reason to
undergo their cardiac catheterization, either to look for “blockages” or examine heart
valves. Only one patient (13%) depicted the main reason as potentially therapeutic (“to
save my life”). When asked the open-ended question of “what is(are) the main reason(s)
for patients to undergo cardiac catheterization?”, without any specific scenario
delineated, most providers (86%) also chose diagnostic purposes, including diagnosing
CAD (either directly listing this, or as a consequence of prior positive imaging or as an
etiology of a cardiomyopathy). As this question was open, many providers listed more
than one “main reason,” and a majority (57%) also chose a therapeutic reason listed in
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the context of a scenario (e.g., revascularization in the setting of acute coronary
syndrome).
Table 17 shows a comparison of patient and provider responses for items on
possible harmful effects.
Table 17. Comparison of Provider and Patient Responses for Harmful Effects of CC
Provider Response
Most common (n=20)
Bleeding/hematoma/vascular
access
Renal damage
“Psychological stressor”
Most serious (n=21)
Stroke/embolic event
Bleeding
Renal damage
Myocardial infarction
Death
Vascular
Medication reaction
Emergent surgery
Infection
Radiation damage
In-stent restenosis

Frequency

16 (76%)
3 (15%)
1 (5%)

Patient Response
Death
Stroke
Heart attack
Reaction to dye
Blood clot
I don’t know

Frequency
(n=8)
5 (63%)
4 (50%)
4 (50%)
1 (13%)
2 (25%)
1 (13%)

19 (90%)
15 (71%)
15 (71%)
10 (48%)
10 (48%)
6 (29%)
4 (19%)
3 (14%)
2 (10%)
2 (10%)
1 (5%)

None of the providers’ stated most common risks were patient stated risks of CC.
However, half the patients listed stroke as a harmful effect of CC, which nearly all
providers (90%) stated as one of the most serious risks. Nearly half of providers (48%)
listed death and myocardial infarction as among the more serious risks of CC, and most
patients also reported death (63%) and half heart attack (50%).
Symptoms that patients should watch for following CC are compared in Table 18.
Patient and providers overlapped in the two most popular responses (access site
complications and chest pain), although in both cases only a minority of patients
described these symptoms. Although neurologic symptoms were popular among
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providers, only a quarter of patients listed neurologic issues. Twenty-five percent of
patients responded “I don’t know.”
Table 18. Comparison of Provider and Patient Responses for Concerning Symptoms
after CC.
Provider Response
Frequency* Patient Response (n=8)
Frequency
(n=21)
(%)
Access site (e.g.,
29
Chest pain/heart attack
3 (37.5%)
bruising, bleeding, pain,
swelling)
Chest pain or recurrent
18
Access site
3 (37.5%)
symptoms
(bleeding, swelling)
Shortness of breath
8
Stroke symptoms
2 (25%)
Not urinating
3
Fever/infection
2 (25%)
Back pain
3
I don’t know
2 (25%)
Fever/chills
2
Shortness of breath
1 (12.5%)
Hives/allergic reaction
1
Blood clot
1 (12.5%)
Nausea/vomiting
1
High blood pressure
1 (12.5%)
Hypotension
1
Neurologic symptoms
“Stroke symptoms”
9
Syncope/light-headed
3
“Neuro dysfunction”
3
Altered mental status
2
Numbness/tingling
2
*Frequency only is shown because of overlapping answers given by the same provider
(e.g., both bleeding and bruising listed as separate answers).
Providers gave several alternatives to CC, both for diagnostic and treatment,
whereas patients gave almost none (Table 19).
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Table 19. Comparison of Provider and Patient Responses for Alternatives to CC.
Provider Response (n-21)
Diagnostic alternatives
Non-invasive imaging without stress
Coronary angiography via CT
Stress testing (treadmill,
echocardiogram, nuclear)
Empiric medical management
Treatment alternatives
Medical management
Exercise/lifestyle modification
Surgery

Frequency

12 (57%)
10 (48%)
17 (81%)
4 (19%)

21 (100%)
2 (10%)
2 (10%)

Patient Response
(n=8)
I don’t know
Ultrasounds

Frequency
7 (87.5%)
1 (12.5%)
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Discussion
This study has elucidated several important aspects of the informed consent
process for cardiac catheterization (CC) from the perspectives of both patients and
providers. In doing so, it helps fill a gap in the literature, not only in directly comparing
patient and provider views, but also in understanding a vulnerable patient population.
The new Capacity to Consent for Cardiac Catheterization (C4) instrument
provides reliable data as evidenced by its internal consistency estimate. The C4 also
shows early evidence of validity as demonstrated by its correlations with educational
level and patient age. Measures of the subdomains of informed consent tested
(understanding, appreciation, and reasoning) and intercorrelations among these
domains, also suggest the construct validity with the small sample of pilot data. This
instrument thus has promise to provide objective measurements of patient
understanding and appreciation of CC, which providers often have trouble measuring.
The C4 instrument now needs to be used to gather data with a larger sample of patients
that will enable full psychometric evaluation of the reliability and validity of the measures.
Regarding patient demographics and performance on the C4, gender by far was
the highest correlated measure (r = 0.82), which reached statistical significance even
with this small sample size. However, a great deal of caution in interpreting this
significance more broadly owes to the fact that all women in this sample had a high
school education or equivalent, whereas men had education that stretched from not
completing high school to a professional degree.
By the criterion identified by providers, most patients in this study (75%) did not
qualify as meeting the minimal threshold of understanding and appreciation of CC to
provide informed consent. By the time patients had completed the CC informed consent
C4 assessment, the full CC informed consent discussion had already taken place, and
all patients had formally signed consent for the procedure to continue. Nevertheless, all
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studied patients subsequently underwent CC. This discrepancy may be due to
differences in the clinical judgment of providers at the time of the consent discussion
versus consideration of a more abstract scenario. Another interpretation may also be
that providers consistently overestimate patients’ understanding and appreciation of CC
in practice. Still, this discrepancy within an institution is evidence of a more nuanced
view of informed consent than is afforded by this study.
Regarding the application of pressure, providers rated applying pressure to
families to influence a patient’s decision to undergo CC as less ethical than providers
applying pressure to patients directly, or family applying pressure to patients.
Interestingly, this finding is in contradiction to what many providers described in
interviews, which show more willingness to involve family in these difficult situations.
Such inconsistency may owe to the idiosyncrasies among providers interviewed, a
subsample of those surveyed who directly participate in performing CC. The
contradictory attitudes seen from surveys with interviews also align with an issue
elucidated during the interviews that, so long as the consent form is signed, providers
are typically willing to perform CC, almost regardless of the circumstances of signing and
lingering doubts. In contrast to providers, all patients thought that providers should apply
pressure in such circumstances, should they initially refuse to undergo a procedure that
providers feel would be beneficial. In fact, two patients invoked the Hippocratic oath in
detailing providers’ obligations to patients in emergent situations.
The literature specifically examining patient perspectives on CC is limited. One
such study (21) showed patients underestimate the risks involved, and this study does
similarly. This is also in keeping with clinical informed consent studies for other medical
procedures, in which patients have difficulty enumerating risks of the procedure (37).
Several providers described concern regarding “information overload,” with a particular
emphasis on “over focusing” on the risks, rather than the potential benefits of the
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procedure. Providers must therefore maintain a careful balance in disclosure of the most
germane “material risks” (38) necessary to be adequately informed about the procedure,
without simply listing an inordinate number of risks that have been described in the
literature (including case reports). In this survey providers consistently described similar
“most common” and “most serious” potential risks as is found in wider patient information
publications (39): bleeding/hematoma, damage from contrast, stroke, myocardial
infarction, need for emergent surgery, and death. Although not listed, a description of
common sensations (e.g., soreness at the access site) in addition to such a brief list of
most common and most serious effects may give providers a consistent common
starting ground on which to tailor individualized discussions.
In describing their decision-making process, patients made the contradictory
claims to feel freedom of choice in deciding whether or not to undergo CC, while at the
same time expressing a tendency to go along with the recommendations of the provider.
Despite feeling free, the patients interviewed did not display a careful weighing of risks
and benefits of the procedure in order to make the decision. Instead, they emphasized
the recommendations of their providers in the context of personal goals (e.g., a return to
normalcy), and they also portrayed a sizable influence of family members (often
superseding their own personal interests), as well as often stating they felt as though
they “had to have” the procedure. This type of decision-making appears to be more
emotional than rational, and tied to the trust patients have in their providers. The
informed consent discussion, as interpreted by patients, served as more of an
information delivery construct than an attempt at actively involving patients in the
decision-making process. Such an attitude may fit well with provider attitudes about the
consent process in the emergent setting, when time pressure plays a large role in
ensuring patients receive the best care possible. In these cases, providers describe
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giving informed consent “a short shrift,” with the focus on getting patients to the
catheterization laboratory as quickly as possible.
Furthermore, informed consent discussion itself appears to have a diminished
role compared to other influences on decision-making (including apparent emotional
rather than rational judgments). This may help explain the low scores on the C4
instrument, as well as the discrepancy between the high self-rated (subjective) scores by
patients and their lower scores on the objectively scored C4. That is, because patients
may have felt as though they had enough information to make a decision, the structured
information provided during the consent discussion did not influence this significantly
and the specific risks and so forth outlined in the discussion made less of an impression.
In other words, because patients tend to feel the procedure is more a necessity than a
choice, encouraged by family and trusting in their providers, the consent discussion
before the procedure may have little influence on patient decisions. This finding is not
unique to this study, as other qualitative studies on patient decision-making have also
found similar reasoning (40).
Despite provider admissions of significantly abbreviating the consent process in
emergencies, providers do express a commitment to ensuring that patients were
adequately informed about CC. All providers described at least one technique for
gauging how well patients understood the information being presented. These methods
included asking patient questions and having them explain the procedure and
associated benefits and risks, and paying close attention to patient body language.
However, the finding that most patients did not qualify as being adequately informed, as
judged by scores less than 70% on the C4 instrument, is contradictory to the
commitment to informed consent expressed by providers. Curiously, some providers had
an almost superstitious outlook regarding adequately informing patients: that they are

51
more likely to have a “bad outcome” with a patient who does not give “appropriate”
informed consent.
This study highlights several tensions inherent in the notion of informed consent
in clinical practice as currently understood. Informed consent is predicated upon patients
making a rational decision in the best interest of their health (2, 41). However, this
consent paradigm may not be as valid in the clinical setting, where individual patient
choices may be constrained by outside influences (5). Others have ascertained that the
consent discussion does not necessarily play a large role in patient decisions to undergo
a procedure (40). This study has similar implications, and the finding that trust in
providers played a large factor in deciding to undergo CC has precedence in other
medical fields (42-44). Based on these patient responses, this “entrustment model” of
informed consent (42, 43), which also depends on providers being transparent in their
thought processes (43, 45), may be more relevant to the population studied herein rather
than the more rational patient autonomy model that is emphasized in informed consent
in research situations. In addition, the entrustment model seems to offer a bridge in
understanding the tension displayed between beneficence and autonomy in the
emergent setting (46) with which providers interviewed consistently struggled.
The limitations of this study are several. First, this is a single-site pilot study
looking at small samples of providers and patients served by the University of New
Mexico Hospital, and although some findings of this study integrate well with the existing
literature, applicability to other institutions or populations may be limited. The providers’
degree or composition of prior training in the process of informed consent is unknown,
and may have had an impact on the quality of consent. Although this study did not
investigate inter-provider variability, having a variety of providers involved attempted to
mitigate this factor. At this institution, there is currently no method of validating the
quality of those involved in obtaining consent or in training junior providers to do so.
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Further, consent discussions were not recorded in this study, and thus their quality
cannot be assessed. The length and quality of the provider-patient CC informed consent
discussions may have varied widely. In previous studies, total consent time served as an
important predictor of understanding (47), and time involved may have influenced patient
understanding in this study. Specific providers involved in the consent process of the
patients studied were not interviewed. Lastly, this study may have a selection bias in
only interviewing patients who had provided consent. The current rate of refusal to
undergo CC at this institution is unknown.
This study also provides the groundwork for additional investigations in on
informed consent procedures and processes for cardiac catheterization. Extension of
this method into non-English speaking populations might yield further insight into this
very vulnerable patient population, including influences on decision-making as well as
measuring capacity for consent. At the University of New Mexico, several providers have
Spanish as their primary language, and the effects of this (versus use of interpreter) on
capacity may also be assessed in future studies. Provider interviews to elicit comfort with
non-English speakers and receiving informed consent may also prove useful in
developing methods to overcome these obstacles. The information gathered from patient
interviews in this study can be used to influence patient understanding and appreciation
of the risks, benefits, and alternatives for cardiac catheterization and to inform providers
to help them engage in improved informed consent procedures. For example, using
methods geared more toward emotional understanding than a listing of rational facts
may help providers better inform their CC patients. The Capacity to Consent for Cardiac
Catheterization instrument developed for this study can serve as an objective
measurement to evaluate methods of improving patient capacity specifically for CC.
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Appendix 1
Provider Survey of Knowledge and Beliefs
about Informed Consent for Cardiac Catheterization
Instructions: Please provide your best estimate to each question below. Please do not
put your name or other identifiers on this survey. The survey should take about 5 to 10
minutes to complete.
1. What is(are) the main reason(s) for patients to undergo cardiac catheterization?
____________________________________________________________________
2. What is the most common serious harmful effect on patients from cardiac
catheterization?
____________________________________________________________________
3. What are the 4 most serious harmful effects from cardiac catheterization that you want
patients
to know and appreciate?
a. ____________________________________________________________
b. ____________________________________________________________
c. ____________________________________________________________
d. ___________________________________________________________
4. If a patient was tested on his or her understanding of basic cardiac catheterization
procedures and his or her appreciation of the related risks and benefits, what percent
correct of informed consent-related questions should the patient answer correctly to be
considered able to consent for the procedure?
______ percent correct
5. After a patient undergoes cardiac catheterization, what are the 4 most medically
concerning symptoms that should prompt the patient to call their doctor?
a. ___________________________________________________________
b. ___________________________________________________________
c. ___________________________________________________________
d. ___________________________________________________________
6. If the patient chooses not to undergo cardiac catheterization, what are the alternatives
in diagnosing the patient’s condition that you want to get across to the patients?
__________________________________________________________________
7. If the patient chooses not to undergo cardiac catheterization, what are the alternatives
in treating the patient’s condition that you want the patient to know about?
Please go to page 2 for just a few more questions . . . .

55
Assume as the treating physician, you confidently believe that a specific patient would
best be treated or diagnosed by cardiac catheterization:
8. How ethical is it for you to apply moderate pressure to convince a patient to consent
for the procedure who initially declined consent for the procedure?
0
Not at all
Ethical

1

2

3

4

5
6
Moderately
ethical

7

8

9

10
Completely
ethical

9. How ethical is it for the patient’s family members to apply moderate pressure to
convince a patient to consent for the procedure who initially declined consent for the
procedure?
0
Not at all
Ethical

1

2

3

4

5
6
Moderately
ethical

7

8

9

10
Completely
ethical

10. How ethical is it for you to apply moderate pressure to a patient’s family members to
convince the patient to consent for the procedure when the patient initially declined
consent for the procedure?
0
Not at all
Ethical

1

2

3

4

5
6
Moderately
ethical

7

8

9

10
Completely
ethical

11. In general, what is your best estimate of the probability that a patient will experience
a serious adverse event when having a cardiac catheterization (we realize, of course,
that the probability of serious adverse events is dependent on patient’s specific medical
condition)?
______ % probability that a serious adverse event will occur
______ % probability of death as a result
12. Please provide your best estimate of the number of patients for which YOU
personally have conducted consent procedures for cardiac catheterization.
______ number of patients during my career (best estimate please)
______ number of patients in the past 12 months (best estimate please)
13. What is your current level of training?
__ attending cardiologist
14. What is your gender?

__ cardiology fellow
__ male

__ resident physician
__ female

15. How many years of clinical practice after training have you completed?
______ years experience
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